Some patients may respond with a delay to the treatment, so the patient's clinical condition should be assessed and a follow-up should be considered a few weeks after the first infusion. The effectiveness of immunoglobulin treatment should be evaluated after at least 3 infusions. No significant...
Treatment of UGIB via TAE has a high technical success rate (69%-100%) and is associated with lower complication rates than transcatheter vasopressin infusion 36, 37, 38, 39, 40. Angiography can identify a bleeding source in up to 80% of cases, with a primary success rate for TAE of ...